CAPO Award

Award for Excellence in Psychosocial Oncology

This annual award is presented to a member of the Canadian Association of Psychosocial Oncology (CAPO) to acknowledge the important work of psychosocial oncology professionals. CAPO members are invited to submit abstracts, for the annual CAPO conference. Abstracts may reflect clinical practice, education or research related to the neuro-oncology population.

Award Amount: $1,500.00 (along with a framed recognition certificate)

2017 CAPO Award Winner

Dr. Tom Hack - CAPO Award Winner

Congratulations to Dr. Tom Hack! 

Tom was involved in a randomized controlled trial of consultation recording use to enhance psychosocial wellbeing and coping behaviour in patients with brain tumours.

Thomas F Hack, PhD
Director, Psychosocial Oncology & Cancer Nursing Research, I.H. Asper Clinical Research Institute, Senior Scientist, Research Institute in Oncology and Hematology at CancerCare Manitoba, Professor, College of Nursing, Rady Faculty of Health Sciences, University of Manitoba, Visiting Professor, University of Central Lancashire, Preston, UK

Pictured: Todd Goold - Brain Tumour Foundation of Canada, Dr. Tom Hack and CAPO Vice President Dr. Fiona Schulte

2016 CAPO Award Winner

Mark Collins CAPO Award Winner 2016

Congratulations to Mark Collins!

The research was titled: “Predicting survival of individuals with high-grade brain tumours using neuropsychological test measures”

By Mark Collins and co-author Dr. Mariani 

Pictured: Mark Collins receiving his award from Todd Goold, Brain Tumour Foundation of Canada 
 

2015 CAPO Award Winners

Dr Ozier with his recipient certificateCongratulations to the 2015 recipients (in order of authorship): Dr. Douglas Ozier (PhD), Dr. Matias Mariani (PhD) and Maureen Parkinson (M.Ed., C.C.R.C.).

Dr Ozier and Maureen Parkinson are affiliated with: BC Cancer Agency, Provincial Psychosocial Oncology, Vancouver, BC.

Dr. Mariani is affiliated with: Supportive Care Program and Supportive Care Oncology Research Unit, Health Sciences North, Sudbury, ON.

Their research was titled, "A remote intervention to improve emotional and cognitive functioning in brain tumour survivors."

Pictured: Dr Douglas Ozier holding his recognition certificate.

2014 CAPO Award Winner

Douglas Ozier CAPO award winner with Koye Oyerinde of Brain Tumour Foundation of CanadaCongratulations to Dr. Douglas Ozier, the recipient of the 2014 CAPO Award.

The research was titled, ""Heart Rate Variability Biofeedback for Anxiety and Depression in Primary Malignant Brain Tumour Patients."
 

Pictured: Dr. Douglas Ozier (left) and Koye Oyerinde, Support Services Specialist at Brain Tumour Foundation of Canada. Photo courtesy of CAPO.


 

2013 CAPO Award Winner

Congratulations to Dr. Matias Mariani, the recipient of the 2013 CAPO Award.

Dr. Mariani's research was titled, “Neuropsychological profiles in individuals with brain tumours”.

2012 CAPO Award Winner

Congratulations to Maureen Parkinson, the recipient of the 2012 CAPO Award.

Her research was titled, “Changes in quality of life, functional activities and cognitive function from baseline to six-months post-treatment for patients with high grade gliomas."

 

 

 

2011 CAPO Award Winner

Congratulations to Dr. Matias Mariani, the recipient of the 2011 CAPO Award.

Dr. Mariani's research was titled, "Aphasia in patients with primary brain tumours: A neuropsychological approach."

Cognitive impairments significantly affect the quality of life of patients undergoing or having completed cancer treatment. Although cognitive deficits may be present as adverse effects of treatment to other cancer sites, the most substantial deficits are observed in patients with brain tumours. Language deficits are common among those affected by brain tumours and tend to be associated with declines in communication, mood and ability to perform activities of daily living. A neuropsychological assessment serves to evaluate and quantify functioning issues leading to an optimized treatment plan.

This presentation outlines the neuropsychological profiles of 5 patients with left-sided primary brain tumours.

The goals are as follows:

  • To review the classification of aphasia syndromes.
  • To provide framework for evaluating language disorders via neuropsychological assessment.
  • To differentiate between various disorders that present with communication problems.
  • To provide strategies to rehabilitate cognitive deficits (including language) and improve quality of life in patients with primary brain tumours.

2010 CAPO Award Winner

Congratulations to the recipient of the 2010 award: Dr. Kim Edelstein, a Neuropsychologist with Princess Margaret Hospital for her work researching the neurocognitive late effects of treatment in adult survivors of childhood cancer.

2009 CAPO Award Winners

Congratulations to the recipients of the 2009 award: Dr. Robert Olson, Hannah Carolan, Ann-Lousie Ellwood, Maureen Parkinson, Kyle Ferguson, Dr. Grant Iverson and Michael McKenzie for their research, Comparison of Two Cognitive Screening Measures, the Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA), in patients with brain tumours.

Identifying cognitive impairment is important in patients with brain tumours. Because neuropsychological evaluations are usually not available, brief screening measures are often used. The Mini Mental State Examination (MMSE) is most commonly employed, despite no validation in this setting. The Montreal Cognitive Assessment (MoCA) is an alternative. In this study, the research team compared the sensitivity and specificity of these screening measures for identifying cognitive impairment.

The recent Canadian Association of Psychosocial Oncology Conference was held in Vancouver, British Columbia during the week of April 1st, 2009. Congratulations and thank you so much to all of the psychosocial oncology professionals who do so much in the fight against brain tumours.

2008 CAPO Award

In May 2008 Brain Tumour Foundation of Canada Award in support of Psychosocial Oncology Excellence was presented to Dr. Guy Pelletier and Tracey Wornsbecker at the Canadian Association of Psychosocial Oncology national conference.

The duo received their award for their research entitled, Quality of Life of Spousal Caregivers of Primary Malignant Brain Tumour Patients. The cross-sectional study documented negative outcomes such as emotional distress and relationship adjustment problems experienced by the spouses of patients with primary malignant brain tumours and also explored the determinants of the problems and the extent to which they correlated with each other.Congratulations to Dr. Pelletier and Ms. Wornsbecker.

< Back to HCP Awards

Share This

Featured Story

Grey Matters - Blogger Tuesdays

Have you seen our blog lately? Read about people who are making a difference in the brain tumour community from our staff and volunteers to our donors, funded researchers, and medical experts. You will find advice, news, information, and interesting stories about people affected by a brain tumour. Who doesn't love a good story? You won't want to miss the inside scoop Grey Matters has in store for you!

Learn more

Spotlight

Roy and the Gamma Knife – A Happy Tale

I had headaches, almost daily, for 10 years or more. It was a rare day if I did not have a headache. I used to joke that I should own...

Learn more

Courtney’s Story of Stability

Stability. It’s a strange concept when you have what it known to be a progressive, life long illness. You hear the words, “Your tumour...

Learn more

Upcoming Events

  • 20/Apr/2018: Caregiver Wellness Day: Royal Oaks Golf Club, Moncton, NB... Learn more >
  • 25/Apr/2018: Toronto Support Group: Meets at Wellspring Westerkirk House at Sunnybrook, Toronto, ON... Learn more >
  • 25/Apr/2018: Ottawa Support Group: Meets at the Maplesoft Centre at 1500 Alta Vista Drive, Ottawa, ON.... Learn more >
  • 26/Apr/2018: Brain Fair: BMO Centre, 295 Rectory St, London, ON... Learn more >
View All Events >
Thank you to the donors whose contributions make this website and all programs, services and research possible.

Copyright © 2018 Brain Tumour Foundation of Canada. Charitable Registration #BN118816339RR0001